Oral Clofarabine for Acute Myeloid Leukemia
NCT00727766
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG:
Clofarabine
Sponsor
Washington University School of Medicine